Delivery Order 75F40120D00028-75F40120F19001

Award Date 9/30/20
Potential Completion Date 9/29/21
Potential Value $1.7M
Ultimate Awardee
CVS Health Corporation
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Hartford, CT 06156, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services, Food and Drug Administration awarded a $24,519,103.59 Delivery Order contract to CVS Health Clinical Trial Services LLC, a subsidiary of CVS Health Corporation. The contract supports the BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS, which involves providing data sources and conducting surveillance of biological drug safety. The contract is a Time and Materials type with a period of performance...
This is a delivery order awarded by the Food and Drug Administration (FDA) to CVS Healthspire Payor & Life Sciences LLC, a subsidiary of CVS Health Corporation, for the CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: HEALTH CARE DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS (BEST 3). The contract is a time and materials agreement with a ceiling value of $1,381,573.96 and a period of performance through September 29,...
The Department of Health and Human Services Food and Drug Administration awarded a $2.68 million delivery order against the BEST Initative - Data Sources For Surveillance of Biologics master IDIQ to Iqvia Government Solutions Inc. The one-year order, with a period of performance from September 2020 through September 2021, will provide products and services in support of the BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS effort. Under a time...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $2.9 million delivery order to International Business Machines Corporation (IBM) under the BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics indefinite-delivery/indefinite-quantity (IDIQ) multiple award contract. The delivery order is for IBM to conduct surveillance activities to assess the safety and effectiveness of biologics, as part of HHS FDA's BEST Initiative. Major...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $13.2 million delivery order contract to International Business Machines Corporation (IBM) under the Biologics Effectiveness and Safety (BEST) Initiative - Data Tools and Infrastructure for Surveillance of Biologics indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The contract calls for IBM to provide data, tools, and infrastructure to support HHS FDA's BEST Initiative for surveillance of...
The Department of Health and Human Services Food and Drug Administration awarded a $5,273,171.50 delivery order contract to Iqvia Government Solutions Inc. to conduct surveillance activities for the safety and effectiveness of biologics. This contract is part of the BEST Initiative, a larger indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle for data tools and infrastructure to support surveillance of biologics. Iqvia Government Solutions is a for-profit organization that has...
This $498,152 firm-fixed price contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) to CVS Health Clinical Trial Services LLC, a subsidiary of CVS Health Corporation. The contract is for CVS Health to provide clinical decision support to align COVID-19 testing and vaccine breakthrough monitoring, as well as identify, secure, and produce related data. This contract is not associated with...
This is a $5,967,111.25 delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to IQVIA Government Solutions Inc., a provider of healthcare data, analytics, and related services to U.S. federal agencies. The contract was awarded under the FDA's BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract is for the development and...
This federal contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Acumen LLC, doing business as Medric, to develop and enhance the FDA's Center for Biologics Evaluation and Research (CBER) capabilities with respect to electronic health data sources, infrastructure, methods, and tools. The purpose is to conduct surveillance and epidemiologic studies to assure the safety and effectiveness of biologic products including vaccines, blood...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to the International Business Machines Corporation (IBM) on September 24, 2019. The $5,622,942.08 time and materials contract is a delivery order under the BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics master IDIQ contract vehicle. The objective is for IBM to conduct surveillance activities to assess the safety and effectiveness of biologics. This work...

The Department of Health and Human Services Food and Drug Administration awarded a $1.7 million delivery order against the BEST Initiative - Data Sources for Surveillance of Biologics master IDIQ to CVS Health Clinical Trial Services LLC. The order is for BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS: "BEST 3": HEALTHCARE PATIENT DATA. CVS Health Clinical Trial Services, a subsidiary of CVS Health Corporation, will provide healthcare patient data to support the FDA's efforts to enhance post-market safety surveillance of biologics through its BEST initiative. Performance will take place in Hartford, Connecticut over a one year period ending in September 2021. The contract utilizes a time and materials pricing structure.

Generated 12/25/23, 12:37 AM